Ignite Creation Date:
2025-12-25 @ 12:09 AM
Ignite Modification Date:
2026-01-01 @ 8:50 AM
Study NCT ID:
NCT00674258
Status:
UNKNOWN
Last Update Posted:
2008-05-14
First Post:
2008-05-05
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Histocompatibility Leukocyte Antigen (HLA)-A*2402 Restricted Peptide Vaccine Therapy in Patients With Non-Small Cell Lung Cancer
Sponsor:
Tokyo University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-05
Start Date Type:
None
Primary Completion Date:
2009-04
Primary Completion Date Type:
ESTIMATED
Completion Date:
2009-04
Completion Date Type:
ESTIMATED
First Submit Date:
2008-05-05
First Submit QC Date:
None
Study First Post Date:
2008-05-07
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2008-05-12
Last Update Post Date:
2008-05-14
Last Update Post Date Type:
ESTIMATED